BioSpace News Archive

Business

IXICO plc: Half Yearly Report to 31 March 2019

IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, today announces its unaudited interim results for the six months ended 31 March 2019.

May 22, 2019
·
3 min read
Centauri’s AlphamerTM Platform highlighted at 4th Annual Advances in Immuno-Oncology Congress

Centauri Therapeutics (“Centauri”), an immunotherapy company active in oncology and infectious diseases, announces that Mel Glossop, Head of Chemistry at Centauri, presented at the 4th Annual Advances in immune-Oncology Congress London, on 20 – 21 May.

May 22, 2019
·
1 min read
BioForest

Neovasc Announces Positive Two-Year Follow-up Safety and Efficacy Data for the Neovasc Reducer™ in a Peer Reviewed Article in the International Journal of Cardiology

Neovasc Inc. announced that the International Journal of Cardiology has published a peer reviewed article regarding long term sustained efficacy and safety of the Reducer therapy in 50 patients suffering from refractory disabling angina.

May 22, 2019
·
9 min read
Deals

Medicure Q1 2019 Results and Conference Call Dates

Medicure Inc., a pharmaceutical company, will release financial results for the quarter ended March 31, 2019 on Monday, May 27, 2019.

May 22, 2019
·
1 min read
Genetown

Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure to Direct Oral Anticoagulants for Stroke Risk Reduction Post-AFib Ablation

Findings could expand number of patients who can receive alternative treatment to life-long use of blood thinners

May 22, 2019
·
6 min read
Business

Taro Provides Results for the Year Ended March 31, 2019

Taro Pharmaceutical Industries Ltd. provided unaudited financial results for the quarter and year ended March 31, 2019.

May 22, 2019
·
7 min read
Business

UnitedHealthcare and Optum Take Action to Support People Affected by Flooding in Missouri

UnitedHealthcare and Optum, the health benefits and services companies of UnitedHealth Group (NYSE: UNH), are taking action to help people affected by recent flooding across parts of Missouri.

May 22, 2019
·
2 min read
BioCapital

Ascentage Pharma to Present New Data at 2019 ASCO Annual Meeting from Clinical Trials of MDM2-p53 Antagonist and IAP Inhibitor in Cancers

Ascentage Pharma announced the presentation of new clinical data for its investigational apoptosis-targeted drug candidates at the 55th Annual Meeting of the American Society of Clinical Oncology in Chicago from May 31-June 4.

May 22, 2019
·
3 min read
Deals

IDEAYA Announces Pricing of Initial Public Offering

IDEAYA Biosciences, Inc. announced the pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $10.00 per share, before underwriting discounts and commissions.

May 22, 2019
·
2 min read
Deals

Bicycle Therapeutics Announces Pricing of Initial Public Offering

Bicycle Therapeutics plc announced the pricing of its initial public offering in the United States of 4,333,333 American Depositary Shares representing 4,333,333 ordinary shares at an initial public offering price of $14.00 per ADS, before underwriting discounts and commissions.

May 22, 2019
·
2 min read